Psa-013/20200058 (Keg) (Foremost)
Research payments
$5,432,903
Through program year 2021, $5,432,903 in research payments was reported against Psa-013/20200058 (Keg) (Foremost), across 56 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $5,432,903 | 56 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Abrar Qureshi Providence, RI Named on 4 payments
- Joshua Sundhar Voorhees, NJ Named on 4 payments
- Andrew Sulich Saint Clair Shores, MI Named on 3 payments
- Dhiman Basu Colleyville, TX Named on 2 payments
- Suneet Grewal West Hollywood, CA Named on 2 payments
- Steven Klein Hagerstown, MD Named on 2 payments
- Alan Kivitz Duncansville, PA Named on 2 payments
- Samy Metyas Covina, CA Named on 2 payments
- Michael Bubb Gainesville, FL Named on 2 payments
- Jacob Aelion Jackson, TN Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.